Vyne Therapeutics Inc (VYNE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER, NJ 08807

VYNE's mission is to improve the lives of patients by developing proprietary, innovative and differentiated therapies in dermatology and beyond.

Data as of 2021-07-19 09:44:44 -0400
Market Cap138.23 Million Shares Outstanding51.387 Million Avg 30-day Volume966.632 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE0.56 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.11836 52-week High/Low11.2 / 1.3 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from VYNE instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 2 -100.0% 0 (0.0%) 2 (0.12%) -100.0%
Funds Holding: 4 107 -96.26% 2 (0.12%) 34 (1.97%) -94.12%
13F shares: 250.305 Thousand 21.93 Million -98.86% 250.18 Thousand 11.656 Million -97.85%
% Ownership 0.4876 13.0632 -96.27% 0.4874 6.9434 -92.98%
New Positions: 1 20 -95.0% 7
Increased Positions 37 11
Closed Positions 103 19 442.11% 32 7 357.14%
Reduced Positions 2 23 -91.3% 2 10 -80.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding VYNE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VYNE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

12.5 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BASTA STEVEN L

  • Director
20,500 2021-07-19 2

SANDOVAL ELISABETH

  • Director
20,500 2021-07-19 2

BRUNO ANTHONY D

  • Director
20,500 2021-07-19 2

BRIGHT REX

  • Director
20,500 2021-07-19 2

BARBARI SHARON

  • Director
20,500 2021-07-19 3

LEPORE PATRICK G

  • Director
20,500 2021-07-19 6

WILEY MATTHEW T. CHIEF COMMERCIAL OFFICER

  • Officer
109,246 2021-06-30 6

STUART IAIN CHIEF SCIENTIFIC OFFICER

  • Officer
95,750 2021-06-30 5

HARSCH MUTYA CHIEF LEGAL OFFICER AND GC

  • Officer
105,322 2021-06-30 6

DOMZALSKI DAVID PRESIDENT AND CEO

  • Officer
  • Director
455,599 2021-06-30 8

ZERONDA TYLER INTERIM CFO

  • Officer
22,695 2021-06-30 2

SAIK ANDREW CHIEF FINANCIAL OFFICER

  • Officer
116,468 2021-05-28 4

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
5,773,954 2021-05-06 1

HIRSCH STANLEY

  • Director
530,019 2020-04-03 0

HADAR ILAN CFO AND COUNTRY MANAGER

  • Officer
0 2020-03-09 0

BALL KRISTINE M SEE REMARKS

  • Officer
52,534 2019-12-11 0

KWON PAUL CHIEF SCIENTIFIC OFFICER

  • Officer
52,534 2019-12-11 0

KRASNOW RONALD A. SEE REMARKS

  • Officer
15,819 2019-12-11 0

EBEL TED

  • Director
0 2019-06-25 0

MCGIRR DAVID W J

  • Director
0 2019-06-25 0

ROYSTON AARON

  • Director
0 2019-06-25 0

WHITCUP SCOTT M

  • Director
0 2019-06-25 0

BERNS PAUL L

  • Director
0 2019-06-25 0

SPELLMAN MARY CHIEF MEDICAL OFFICER

  • Officer
0 2018-12-10 0

PRESIDIO PARTNERS 2007 GP, L.P.

PRESIDIO PARTNERS 2007 (PARALLEL), L.P.

PRESIDIO PARTNERS 2007, L.P.

COLLIER DAVID J

WATSON JAMES F

SOHAIL FAYSAL A.

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-07-24 0

FMR LLC

  • SEE REMARK 1
No longer subject to file 2018-01-29 0

CHA ALBERT

  • Director
7,272,328 2018-01-25 0

VENBIO GLOBAL STRATEGIC FUND II L.P.

  • 10% Owner
No longer subject to file 2018-01-25 0

REMEDITEX VENTURES LLC

  • 10% Owner
2,761,663 2018-01-25 0

VIVO CAPITAL VIII, LLC

VIVO CAPITAL SURPLUS FUND VIII, L.P.

VIVO CAPITAL FUND VIII, L.P.

  • 10% Owner
7,272,328 2018-01-25 0

MERCK & CO., INC.

MERCK SHARP & DOHME CORP.

  • 10% Owner
1,243,168 2018-01-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BARBARI SHARON - Director

2021-07-20 17:04:13 -0400 2021-07-19 A 20,500 a 20,500 direct

BRUNO ANTHONY D - Director

2021-07-20 17:05:57 -0400 2021-07-19 A 20,500 a 20,500 direct

LEPORE PATRICK G - Director

2021-07-20 17:06:13 -0400 2021-07-19 A 20,500 a 20,500 direct

BASTA STEVEN L - Director

2021-07-20 17:04:39 -0400 2021-07-19 A 20,500 a 20,500 direct

SANDOVAL ELISABETH - Director

2021-07-20 17:06:33 -0400 2021-07-19 A 20,500 a 20,500 direct

BRIGHT REX - Director

2021-07-20 17:05:03 -0400 2021-07-19 A 20,500 a 20,500 direct

WILEY MATTHEW T. - Officer CHIEF COMMERCIAL OFFICER

2021-07-02 16:36:53 -0400 2021-06-30 F 5,151 $3.51 d 109,246 direct -2.2152 -6.0127 0.0 1 -6.0127 6

STUART IAIN - Officer CHIEF SCIENTIFIC OFFICER

2021-07-02 16:36:27 -0400 2021-06-30 F 3,083 $3.51 d 95,750 direct -2.2152 -6.0127 0.0 1 -6.0127 6

DOMZALSKI DAVID - Director - Officer PRESIDENT AND CEO

2021-07-02 16:35:47 -0400 2021-06-30 F 18,859 $3.51 d 455,599 direct -2.2152 -6.0127 0.0 1 -6.0127 6

ZERONDA TYLER - Officer INTERIM CFO

2021-07-02 16:37:31 -0400 2021-06-30 F 700 $3.51 d 22,695 direct -2.2152 -6.0127 0.0 1 -6.0127 6

HARSCH MUTYA - Officer CHIEF LEGAL OFFICER AND GC

2021-07-02 16:36:06 -0400 2021-06-30 F 3,551 $3.51 d 105,322 direct -2.2152 -6.0127 0.0 1 -6.0127 6

DOMZALSKI DAVID - Director - Officer PRESIDENT AND CEO

2021-06-02 16:30:55 -0400 2021-05-28 A 941 $3.36 a 474,458 direct -2.7919 3.5533 -31.7259 4.3147 4 -31.7259 31

SAIK ANDREW - Officer CHIEF FINANCIAL OFFICER

2021-06-02 16:31:40 -0400 2021-05-28 A 3,017 $3.36 a 116,468 direct -2.7919 3.5533 -31.7259 4.3147 4 -31.7259 31

LEPORE PATRICK G - Director

2021-05-27 17:18:50 -0400 2021-05-26 P 12,500 $3.60 a 37,500 direct 0.7595 1.2658 -24.8101 4.0506 7 -24.8101 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VYNE THERAPEUTICS INC VYNE 2021-07-23 22:15:03 UTC -0.841 0.921 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 21:45:03 UTC -0.841 0.921 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 21:15:03 UTC -0.841 0.921 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 20:45:03 UTC -0.8678 0.9478 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 20:15:05 UTC -0.8678 0.9478 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 19:45:03 UTC -0.8678 0.9478 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 19:15:03 UTC -0.8678 0.9478 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 18:45:03 UTC -0.8535 0.9335 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 18:15:03 UTC -0.8535 0.9335 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 17:45:03 UTC -0.8535 0.9335 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 17:15:02 UTC -0.8535 0.9335 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 16:45:02 UTC -0.8452 0.9252 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 16:15:03 UTC -0.8452 0.9252 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 15:45:02 UTC -0.8452 0.9252 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 15:15:03 UTC -0.8452 0.9252 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 14:45:03 UTC -0.7541 0.8341 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 14:15:03 UTC -0.7541 0.8341 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 13:45:03 UTC -0.7541 0.8341 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 13:15:03 UTC -0.7541 0.8341 800000
VYNE THERAPEUTICS INC VYNE 2021-07-23 12:45:03 UTC -0.7541 0.8341 800000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments